LENSAR (NASDAQ:LNSR - Get Free Report) will likely be announcing its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $14.95 million for the quarter. Investors interested in participating in the company's conference call can do so using this link.
LENSAR Price Performance
NASDAQ LNSR traded down $0.60 during trading hours on Friday, reaching $9.29. 57,412 shares of the stock traded hands, compared to its average volume of 88,392. The company has a market cap of $107.90 million, a price-to-earnings ratio of -6.36 and a beta of 0.66. The stock has a 50 day simple moving average of $9.26 and a two-hundred day simple moving average of $6.81. LENSAR has a 1 year low of $2.67 and a 1 year high of $12.13.
About LENSAR
(
Get Free Report)
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Featured Stories
Before you consider LENSAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LENSAR wasn't on the list.
While LENSAR currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
